Russia has temporarily stopped vaccinating young volunteers taking part in clinical trials with its own Russian coronavirus vaccine due to high demand and lack of vaccine doses, a spokesman for the study company said today, noting a setback in “This is due to the fact that there is a huge demand for the vaccine and they are not producing enough to meet it,” said a spokesman for Crocus Medical, a contracted research organization According to unofficial information, vaccinations will resume on November 10, he said. Staff members at eight of Moscow’s 25 hospitals where clinical trials of the vaccine are being conducted, Reuters that the vaccination of young volunteers participating in phase III of the class The vaccine has been temporarily suspended, with several attributing this development to high demand and lack of vaccine doses. Asked about the temporary discontinuation of clinical trials and the low availability of vaccine doses, Russian Health Ministry adviser Alexei Kuznetsov said that clinical trials of the vaccine in volunteers were continuing. The Moscow Gamale Institute, which develops and produces the Russian Sputnik-V vaccine, referred the agency to the Russian Ministry of Health. Earlier, Russian President Vladimir Putin said that Russia had a problem with of the Russian vaccine against Covid-19, due to the potential of the existing equipment, but expressed the hope that the mass vaccination of the population will begin by the end of the year.
- Tsakiri-Kafouni meeting for the financing of small enterprises
- Ministry of Infrastructure: Eight changes to the law on public procurement